Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Arthritis (Musculoskeletal) - Drugs in Development, 2021
US$ 2,000.00
Arthritis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Arthritis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Arthritis pipeline landscape. The report provides...
April 2021
105 pages
Ascites (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Ascites (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Ascites (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Ascites pipeline landscape. The report provides comp...
April 2021
30 pages
Astrocytoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Astrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Astrocytoma (Oncology) - Drugs in Development, 2021 provides an overview of the Astrocytoma pipeline landscape. The report provides comprehe...
April 2021
55 pages
B-Cell Leukemia (Oncology) - Drugs in Development, 2021
US$ 2,000.00
B-Cell Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY B-Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the B-Cell Leukemia pipeline landscape. The report provi...
April 2021
100 pages
B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021
US$ 3,000.00
B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021 SUMMARY B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021 provides in depth analysis on B Cell Lymphoma 2 (Bcl 2) targeted pipeline therapeu...
April 2021
50 pages
Beta Tubulin (TUBB) - Drugs in Development, 2021
US$ 3,000.00
Beta Tubulin (TUBB) - Drugs in Development, 2021 SUMMARY Beta Tubulin (TUBB) - Drugs in Development, 2021 provides in depth analysis on Beta Tubulin (TUBB) targeted pipeline therapeutics. The report p...
April 2021
30 pages
Biliary Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Biliary Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Biliary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Biliary Tumor pipeline landscape. The report provides co...
April 2021
45 pages
Blepharospasm (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Blepharospasm (Ophthalmology) - Drugs in Development, 2021 SUMMARY Blepharospasm (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Blepharospasm pipeline landscape. The report p...
April 2021
30 pages
